European Commission approves new treatment for severe asthma
Exdensur (depemokimab) is the first and only ultra-long-acting biologic in the EU to treat severe asthma and chronic…
GSK gets FDA approval for Exdensur asthma treatment
Key Terms
eosinophilic phenotype
medical
An eosinophilic phenotype…